ABSTRACT We assessed the effectiveness of an asthma educational programme based on a repeated short intervention (AEP-RSI) to improve asthma control (symptom control and future risk) and quality of life.
Introduction
Education and guidance on asthma self-management have become increasingly important in recognition of the need to improve asthma management, reduce morbidity and lower costs of care. Structured individualised self-management education programmes that include written action plans for adjusting treatment based on the degree of asthma control are effective, and lead to a reduction in the risk of exacerbations and indirect costs, and an improvement in quality of life [1] [2] [3] . Unfortunately, the reality is that there are few healthcare centres and professionals that offer education programmes to their patients with asthma [4] . It has been argued that complexity and high cost are barriers to implementing self-management educational programmes in clinical practice.
Research related to asthma education has examined the simplified approaches of the current programmes intended to focus the content on essential aspects. However, use of limited asthma education (i.e. information only) does not appear to improve health outcomes in adults with asthma [2] . Various types of short-format and short-term educational interventions in asthma patients have been developed [5] [6] [7] [8] . However, these programmes have provided inconsistent results due to differences in terms of design, components of patient education, setting in which the disease is addressed or outcomes considered. Therefore, new evidence from robustly designed studies performed in large samples of patients with asthma and assessing the beneficial effects of a real short-term education programme (rather than instructional interventions only) on asthma symptoms and future morbidity is needed. The aim of this study was to assess the effectiveness of an asthma educational programme based on a repeated short intervention (AEP-RSI) to improve symptoms and quality of life as well as to prevent future asthma exacerbations in adult patients with asthma.
Methods

Study design and participants
Between June 2011 and February 2013, a cluster randomised controlled multicentre study was performed in adult patients with asthma. The objective of the study was to assess the effectiveness of the AEP-RSI to improve asthma symptoms and to prevent asthma exacerbations (future risk), and, consequently, to improve health-related quality of life. The duration of the study was 12 months and all patients included were visited by their physician four times (one visit in every 3 months), when their asthma treatment was adjusted.
A total of 25 centres throughout Spain (15 pulmonology services, one allergy service and nine primary care centres) agreed to participate in the study. Five pulmonology services with recognised excellence in asthma care already administered education interventions to their patients with asthma following the recommended programmes [9] [10] [11] . These were centres with technical resources and professionals specialised in educational programmes in their teams, which have also been recognised as centres with Specialised Asthma Units, the maximum level provided by the Spanish Respiratory Society (SEPAR) in the clinical excellence programme of this society (accreditation programme for asthma units). These centres were not randomised and were included in the "gold standard" group. The remaining 20 centres were randomised to the "intervention" group (administration of the AEP-RSI programme) (n=10) or medical care without such education, the "usual clinical practice" group (n=10).
Patients were consecutively enrolled from the outpatient clinics of the pulmonology and primary care centres involved in the study. Eligibility included men and women aged between 18 and 70 years, with mild-to-moderate persistent uncontrolled asthma. The diagnosis of asthma was accepted when a patient with common clinical symptoms of the disease and airflow limitation had a positive bronchodilator test (⩾12% change in forced expiratory volume in 1 s) or a daily peak expiratory flow variability >20% or a positive methacholine challenge test documented in the medical record. Severity of asthma before treatment adjustment was defined according to the Global Initiative for Asthma criteria [12] and uncontrolled asthma was define as a score <20 in the Asthma Control Test (ACT) [13] . Patients with severe comorbidities or those who had an asthma exacerbation episode that required treatment with oral corticosteroids within 30 days before enrolment were excluded from the study.
The study was conducted in accordance with the Declaration of Helsinki principles (18th World Medical Assembly), and was approved by the Clinical Research Ethics Committee of Hospital de la Santa Creu i Sant Pau (approval number 72/2010) and registered at http://www.clinicaltrials.gov (NCT02282359). Written informed consent was obtained from all participants. Personal identification data were anonymised.
AEP-RSI of the intervention group
Asthma patients enrolled in the intervention centres received the education programme, which was taught on-site by the educator, physician and/or registered nurse. The intervention was implemented in a series of four consecutive visits, which were scheduled every 3 months. The education programme included the following three components: 1) provision of basic information on asthma, 2) provision of a short personalised asthma action plan, and 3) training to use the inhalers devices correctly and revision of the inhaler technique. The three components of the education programme were checked at each study visit.
In relation to general information on asthma, a printed copy of the Spanish Asthma Guidelines (GEMA) for Patients [14] was given to each participant at the first visit. Also, at each of the three subsequent visits, the asthma educator briefly explained five simple recommendations and emphasised the importance to follow these recommendations (table 1) . Supplementary oral information on allergen avoidance measures was also given to those patients who were sensitised.
A short written personalised asthma action plan was established by the physician for each individual patient according to the patient's symptoms. The mini action plan was based in part on the GEMA recommendations [15] and adapted to essential aspects (table 1) . Briefly, as step 1, patients were instructed to triple the dose of inhaled steroids that they were usually receiving and to start reliever medication if they had not done before (inhaled salbutamol, two puffs every 6 or 8 h) for 3-5 days. If not improved (step 2), a short course of oral steroids ( prednisone 30 mg) for 5-10 days was indicated (table 1) . Comprehension of the mini action plan was checked at each visit. Patients were trained in correct inhaler technique using placebo inhaler devices. At each visit, the patient's inhaler technique was checked and technique errors were corrected. Therefore, the AEP-RSI met criteria for an educational intervention, including a teaching method based on a personalised approached tailored to the patient's characteristics, face-to-face reinforcement actions and placebo inhaler devices to check adequacy of the inhaler technique.
To assess the feasibility and time taken to administer the AEP-RSI, a pilot study with five patients was performed. The time (mean±SD) for implementation of the educational programme at the first visit was 10.7±3.8 min and for each of the follow-up visits was 6.4±2.3 min.
In order to standardised the educational messages received by the patients of the AEP-RSI group, their physicians and/or nurses were first trained in an accredited on-line course (http://www.gemasma.com) based on the GEMA recommendations for educators [16] , and then attended a 1-day on-site course in which the AEP-RSI was fully explained, and materials and placebo inhalers were provided.
Asthma education programmes in the gold standard group
Centres of this group administered education interventions following the usual recommended programmes [9] [10] [11] . Briefly, the education programme was implemented by a nurse (trained in communication skills and changing behaviour techniques) to each individual patient coinciding with scheduled medical visits. In the first visit, the programme was fully explained, the patient's concerns, beliefs and expectations were investigated, and a therapeutic goal to which the patient agreed was established. Information was provided on basic asthma concepts (chronic disease, need to take medication uninterruptedly, difference between inflammation and bronchoconstriction, and symptoms) taking into account the clinical characteristics, TABLE 1 Components of the asthma educational programme based on a repeated short intervention implemented in the intervention group at each study visit Five simple asthma-related recommendations 1. Better to prevent asthma exacerbation. Do not forget to take your medication daily and at the doses prescribed. 2. Do not smoke and do not allow other people to smoke in your presence. 3. If you lose control of asthma, ACT!, use the action plan provided to you, but get medical help. 4. Do not take aspirin or its derivatives. 5. In case you suffer from allergy (mite, pets, pollens, etc.) avoid exposure.
Mini action plan
Patient's name: concerns and agreed objective for each patient. Placebo inhalers were used to teach the inhaler technique. In the second visit, adherence to treatment was commented on and the importance of compliance was emphasised; medication was also adjusted to the patient's daily routine activities. Patients were taught about environmental measures, and a written action plan based on symptoms and peak flow measurement at home was provided. Patients were instructed on how to use the peak flow metre device. Patient's knowledge and skills regarding the correct use of inhalers, environmental measures, monitoring of symptoms and written action plan were reinforced at each follow-up visit. Emphasis was placed on the importance of being adherent to the prescribed medication and, in some cases, techniques to prevent forgetfulness were used.
Study procedures
At the first visit (visit 1), patients in the three study groups signed an informed consent, and completed general questions about sociodemographic variables, education level, asthma clinical characteristics and treatment. Patients also completed a Spanish validated version of the ACT [13, 17] . Comorbid conditions were assessed with the Charlson Comorbidity Index [18] and health-related quality of life was assessed with the Mini Asthma Quality of Life Questionnaire (MiniAQLQ) [19, 20] . Spirometry was performed according to European Respiratory Society/American Thoracic Society guidelines [21] , using the predicted values for a Mediterranean population [22] .
Study variables
The primary variable was the control of asthma symptoms assessed by the ACT scores during the study period (visits 1-4). Secondary variables were age, gender, body mass index (BMI), education level (no studies/ primary education, secondary education/university studies), smoking status (current smoker, never-smoker, ex-smoker) and Charlson Comorbidity Index score at visit 1; MiniAQLQ scores and spirometric data at visits 1 and 4; and requirement of short and long oral steroids cycles, hospitalisations, emergency room visits, unscheduled medical visits, asthma exacerbations (defined as a composite variable that included the number of unscheduled medical visits, emergency room visits and hospitalisations), and treatment at all study visits.
Sample size calculation and statistical analysis
The sample size was calculated to detect a statistically significant difference of 4 points in the ACT score (double the minimal clinically relevant value of this test) assuming a mean ACT score of 18 in one of the study groups, with a 50% variability and standard deviation of 9. Thus, accepting 20% of patients lost to follow-up, 200 patients were required to answer the study question (beneficial effects of the AEP-RSI intervention). A significance level of 5% was accepted. The size was somewhat inflated to compensate for a possible intracluster correlation. The minimal power was 80%.
Categorical variables are expressed as absolute and relative frequencies and quantitative variables as mean ±SD. Groups were compared using analysis of variance (ANOVA), Chi-squared test and post hoc Tukey's honestly significant difference procedure when appropriate. An intention-to-treat analysis using last observation carried forward was used for the analysis of the primary variable in the entire population. Analysis of the primary variable also included two-way repeated measures ANOVA, in which factors were time (ACT scores, four levels) and intervention (three levels). Additionally, to correct for the centre's randomisation (cluster analysis study), the ANOVA was performed by adding the centre factor (defined as random), using a mixed procedure, and the a covariance matrix was chosen using the Akaike information criterion [23] ; this analysis was also carried out adding confounding variables such as education level, BMI and MiniAQLQ score. Statistical analysis was performed with SPSS version 21.0 (IBM-SPSS, Inc., Chicago, IL, USA). Statistical significance was set at p<0.05.
Results
After randomisation, one centre from the intervention group and two centres from the usual clinical practice group refused to take part in the study. In one case, the management of the centre finally did not grant permission and the remaining two centres claimed work overload. Therefore, a total of 22 centres with 250 patients were included in the study. However, 10 patients (six in the intervention group and four in the usual clinical practice group) did not complete the follow-up visits, and 10 other patients (one in the intervention group and nine in the usual clinical practice group) did not meet the inclusion criteria and were excluded from the analysis. Data from 230 patients (intervention group, n=114; usual clinical practice group, n=71; gold standard group, n=45) were analysed. The flowchart of the study population is shown in figure 1 .
As shown in table 2, most patients were women, age 46.1±13.7 years and moderate persistent asthma. Statistically significant differences among patients in the three study groups were not found, except for a lower percentage of patients with mild asthma and a higher percentage of patients with moderate asthma in the intervention group as compared with patients in the usual clinical practice group, which resulted in a significantly lower ACT score in the usual clinical practice group than in the intervention group.
ACT score
In relation to control of asthma symptoms, the mean ACT score improved significantly over the 12-month follow-up period in the three groups, with significant differences ( p<0.001) already from the second visit. Progressive improvement in ACT score showed a tendency to flatten at visits 3 and 4 ( figure 2) ; however, at the end of the study, the mean ACT scores were 21.18±0.38 and 20.42±0.60 in the gold standard and intervention groups, respectively, as compared with 19.56±0.45 in the usual clinical practice group ( p=0.042). Significant differences between groups were also found in the mixed ANOVA model ( p=0.039).
Prevention of future asthma-related events
As shown in table 3, patients in the intervention and the gold standard groups suffered from fewer asthma exacerbations as compared with the usual clinical practice group ( p=0.003), which resulted in a lower number of unscheduled medical visits ( p=0.001). Differences in the number of patients requiring inpatient care or differences in spirometric values were not observed. The mean number of both short and long courses of oral steroids was also similar in the three study groups, although there was a trend for a higher use of oral steroids (both short and long courses) in the usual clinical practice group as compared with the intervention and gold standard groups (table 3) .
Health-related quality of life According to the minimal clinical difference for the MiniAQLQ established as 0.5 points [24] , patients in the three groups improved their MiniAQLQ scores at the end of the study as compared with baseline: the intervention group increased 0.95±1.04, the gold standard group increased 0.89±0.84 and the usual clinical practice group increased 0.52±0.97 points. However, the increases observed in the intervention and gold standard groups were significantly ( p=0.019) higher compared with the increase of the usual clinical practice group.
Discussion
Although self-management education programmes are recommended by clinical practice guidelines [12, 15, 25] and expert panels [26] with a high level of evidence, implementation at the clinical level is still limited [4, 27] , which contributes to suboptimal asthma control [28, 29] . This study shows that a short-format repeated educational intervention (AEP-RSI) delivered by trained physicians and/or nurses 25 was more effective to achieve good control of asthma symptoms, to improve quality of life, and to reduce exacerbations and unscheduled medical visits during the 12-month follow-up period compared with usual clinical practice. In terms of other outcomes, including emergency room visits, hospital admissions and oral steroid cycles (long and short courses), data obtained in the intervention group were somewhat worse than data obtained in the gold standard group, but better than those found in the usual care group. The present findings support the benefits of simple and short-format educational programmes. Of note, the mini action plan included three simple premises to easily identify loss of asthma control and three simple progressive therapeutic measures (including the use of oral corticosteroids) to act accordingly. This brief written mini action plan is very easy and quick to explain by healthcare professionals as well as easily understood and followed by patients, overcoming one of the barriers to implementation of action plans, which many patients sometimes perceive as difficult to understand and apply. Although all three study groups showed a significant increase in ACT and MiniAQLQ scores, well-controlled asthma (ACT score >20) was only observed in the asthma education programme groups, either the AEP-RSI intervention group or the gold standard group. Patients in the usual clinical practice group showed less severe asthma at baseline, with a higher percentage of patients with mild asthma as compared with the intervention and gold standard groups; However, asthma-related events at follow-up, including exacerbations and unscheduled medical visits, were significantly worse in the usual clinical practice group than those observed in the other two groups. Moreover, although those in the intervention and gold standard groups were able to self-administer short courses of oral corticosteroids if they became uncontrolled in accordance with their asthma action plans, patients in the usual clinical practice group used oral steroids with the same frequency (even with a non-significant increased use) and showed a higher rate of exacerbations.
Recently, the UK Review of Asthma Deaths, a confidential enquiry that investigated 900 asthma deaths in 2012, showed several deficiencies in patient care and concluded that the majority of asthma deaths could have been prevented [30] . One of the areas of deficit identified was related to the limited use of asthma educational programmes, in particular using personal asthma action plans (less than a quarter of patients who died had one). In contrast, in the Finnish asthma programme launched in 1994, which resulted in a decrease in asthma mortality amongst other outcomes, success was based on four principles, one of which was to educate patients using a written management plan as the preferred method [31] .
Therefore, it has been argued that one of the keys to reduce deaths from asthma may be improving knowledge and skills, leading to a transfer of knowledge to the patient, a form of patient empowerment [32] . In this context, an AEP-RSI may be an easy-to-use tool to achieve the patient implication and could provide some of the answers to the research needs ( pragmatic approaches, implement asthma self-management) recently identified by the International Primary Care Respiratory Group [33] .
Our results are not in agreement with data reported in other studies reporting partial improvements with the use short-format educational programmes. In the study by DALCIN et al. [5] in 115 asthma patients who participated in one individualised session and who were evaluated after 3 months, a significant decrease of patients visiting emergency services was noted, but the level of asthma control did not improve significantly. In the study by MORELL et al. [7] , 334 asthma patients underwent a 5-min educational intervention, which was repeated at 3 months, with a final assessment at 6 months. As compared with control patients, a reduction in the number of exacerbations was observed without significant changes in the control of asthma (according to the asthma control questionnaire). In the study by MANCUSO et al. [6] of 197 patients who attended the emergency department because of respiratory symptoms, a self-management education intervention delivered in the emergency department and reinforced by telephone did not provide any incremental benefit for quality of life and short-term repeated emergency department visit outcomes. In the study by CÔTÉ et al. [8] , 98 patients consulting urgently for an acute asthma exacerbation were assigned to usual treatment, limited education (teaching of the inhaler technique plus self-action plan given by the on-call physician) or the same limited education plus a structured educational programme emphasising self-management. After 12 months, only patients in the structured educational programme showed a significant reduction in the number of urgent visits for an acute exacerbation of asthma and a significant improvement in the quality of life scores.
Regardless of differences in methodology used in these aforementioned studies, which may account for the disparity in the results, better outcomes observed in the present study could be explained primarily by two reasons. First, the AEP-RSI intervention implemented in our study, although brief, met criteria for an educational intervention itself as compared with short-format interventions assessed in other studies [5] [6] [7] [8] in which more instructional-type interventions were used. A therapeutic educational programme should include a teaching method as it is well-known that behaviour remains unmodified when information only or minimal instructions are provided [1, 2] . For this reason, a personalised approach to the disease of each patient is recommended, which should be tailored to the patient's social, cultural and environmental characteristics [34] . Moreover, it has been shown that adult asthma patients have identifiable preferences for active levels of participation in treatment decision making and that communication is an area requiring improvement [35] . Second, the short educational intervention in the AEP-RSI programme included face-to-face reinforcement actions during subsequent clinical visits, including supervision of the inhaler technique using placebo inhaler devices, unlike other studies in which actions included a single or two initial visits [5] [6] [7] [8] , or only telephone reinforcement [6] . It has been established that regular educational opportunities associated with frequent visits by the patient improves the outcomes of educational programmes, benefits patient-physician relationships and results in greater patient engagement in self-management [1, [36] [37] [38] . Finally, it is important to note that patient improvement is part of a structured educational programme, although educational programmes need to be seen in the context of a structured asthma review, such as that proposed in the SIMPLES (smoking status, inhaler technique, monitoring, pharmacotherapy, lifestyle, education and support) primary care approach for adults with difficult asthma [39] .
The cluster randomised controlled design of the study and the set of variables analysed are strengths of the present findings. The ACT score differences between groups at baseline do not limit the results observed, because during the subsequent 1-year follow-up period, significant differences in the changes in the ACT score improvements between groups were observed. It is possible that improvements obtained in the usual practice group may be explained by a Hawthorne effect, but the magnitude of improvements after 12 months was significantly lower than that observed in the AEP-RSI intervention and gold standard groups. Therefore, the potential influence of the Hawthorne effect does not affect the interval validity of the study.
In conclusion, an AEP-RSI provided a significant improvement in asthma control, symptoms and future risk, and health-related quality of life as compared with usual clinical practice. Cost benefits are likely to be associated with the implementation of the programme, but this aspect was not assessed in the present study. Even though short educational interventions should not replace standard and complete self-management educational programmes, the implementation of an AEP-RSI is a pragmatic option to improve the management of asthma patients in centres with limited resources that are lacking standardised asthma educational programmes.
